Oncology
1 drug is in development for Colon Cancer.
- Companies
- 1
- Clinical trials
- 29
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Colon Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| CTX-009 | Compass Therapeutics, Inc. (CMPX) |
About this indication
Colon Cancer context
Oncology·MeSH: Colonic Neoplasms (D003110)
Prevalence
135.0 / 100K
Incidence
36.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Colon Cancer?
BioSniper tracks 1 drug in development for Colon Cancer across 1 company.
How many clinical trials target Colon Cancer?
There are 29 clinical trials targeting Colon Cancer tracked by BioSniper.
What is the prevalence of Colon Cancer?
The estimated prevalence of Colon Cancer is approximately 135.0 per 100,000 population.